May 23rd, 2010
HealthDay – THURSDAY, May 20 (HealthDay News) — The final phase of a drug
study finds that two years of treatment with rituximab (Rituxan) cuts in
half the risk that follicular lymphoma patients who respond to
chemotherapy will suffer a recurrence of the disease.
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – SUNDAY, May 16 (HealthDay News) — New research is shedding light
on how to better use oxygen to treat extremely premature babies.
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – SUNDAY, May 16 (HealthDay News) — It’s well known that food
laden with fat isn’t good for your heart, but now a new study suggests
that fatty meals may affect lung function, too.
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – MONDAY, May 17 (HealthDay News) — Better asthma symptom control
might be a mouse click away, Dutch researchers report.
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – MONDAY, May 17 (HealthDay News) — Despite last month’s passage
of health care reform, a new poll reveals that more than two-thirds of
emergency room doctors believe ER visits will continue to go up.
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – (HealthDay News) — Laxatives are medications usually purchased
over-the-counter to help treat constipation.
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – (HealthDay News) — Giving an infant a bath can be stressful, as
the little one probably hates to get cold.
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – MONDAY, May 17 (HealthDay News) — New research suggests that
exposure to high levels of organophosphate pesticides, commonly found on
berries, celery and other produce, could raise the odds for
attention-deficit/hyperactivity disorder (ADHD) in children.
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
Posted in Calator | Comments Off
May 17th, 2010
HealthDay – MONDAY, May 17 (HealthDay News) — Roxro Pharma’s Sprix
(ketorolac tromethamine) nasal spray has been approved by the U.S. Food
and Drug Administration for the short-term treatment of moderate to
moderately severe pain, the manufacturer said Monday in a news
release.
Posted in Calator | Comments Off